Migraine Drugs Market in Latin America 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	163 Pages	TechNavio	September, 2024	INF19287582

Best Price Guarantee
Price	from $2,500
Length	163 Pages
Publisher	TechNavio
Published Date	September, 2024
SKU	INF19287582

Migraine Drugs Market In Latin America 2024-2028

The migraine drugs market in latin america is forecasted to grow by USD 80 mn during 2023-2028, accelerating at a CAGR of 5.4% during the forecast period. The report on the migraine drugs market in latin america provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of migraine in latin america, growing number of migraine treatment awareness programs, and drug reformulations strengthening vendor portfolios.

Technavio's migraine drugs market in latin america is segmented as below:

By End-user
Hospitals
Retail
Online
By Geographical Landscape
Latin America
By Therapy
Preventive treatment
Abortive treatment

This study identifies the introduction of new classes of drugs with higher clinical efficacy as one of the prime reasons driving the migraine drugs market in latin america growth during the next few years. Also, rise in popularity of devices for migraine treatment and rising advances in migraine drugs will lead to sizable demand in the market.

The report on the migraine drugs market in latin america covers the following areas:

Migraine drugs market in latin america sizing
Migraine drugs market in latin america forecast
Migraine drugs market in latin america industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading migraine drugs market in latin america vendors that include AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Ethypharm SAS, GlaxoSmithKline Plc, H Lundbeck AS, IntelGenx Technologies Corp., Klaria Pharma Holding AB, Kowa Co. Ltd., OptiNose Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and UCB SA. Also, the migraine drugs market in latin america analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Therapy; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Latin America - Market size and forecast 2023-2028 ($ million); Data Table on Regional - Market size and forecast 2023-2028 ($ million); Chart on Latin America: Year-over-year growth 2023-2028 (%); Data Table on Regional - Market size and forecast 2023-2028 ($ million)
4 Historic Market Size: 4.1 Migraine Drugs Market in Latin America 2018 - 2022; Historic Market Size - Data Table on Migraine Drugs Market in Latin America 2018 - 2022 ($ million); 4.2 Therapy segment analysis 2018 - 2022; Historic Market Size - Therapy Segment 2018 - 2022 ($ million); 4.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy: 6.1 Market segments; Chart on Therapy - Market share 2023-2028 (%); Data Table on Therapy - Market share 2023-2028 (%); 6.2 Comparison by Therapy; Chart on Comparison by Therapy; Data Table on Comparison by Therapy; 6.3 Preventive treatment - Market size and forecast 2023-2028; Chart on Preventive treatment - Market size and forecast 2023-2028 ($ million); Data Table on Preventive treatment - Market size and forecast 2023-2028 ($ million); Chart on Preventive treatment - Year-over-year growth 2023-2028 (%); Data Table on Preventive treatment - Year-over-year growth 2023-2028 (%); 6.4 Abortive treatment - Market size and forecast 2023-2028; Chart on Abortive treatment - Market size and forecast 2023-2028 ($ million); Data Table on Abortive treatment - Market size and forecast 2023-2028 ($ million); Chart on Abortive treatment - Year-over-year growth 2023-2028 (%); Data Table on Abortive treatment - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Therapy; Market opportunity by Therapy ($ million); Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 7.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 7.4 Retail - Market size and forecast 2023-2028; Chart on Retail - Market size and forecast 2023-2028 ($ million); Data Table on Retail - Market size and forecast 2023-2028 ($ million); Chart on Retail - Year-over-year growth 2023-2028 (%); Data Table on Retail - Year-over-year growth 2023-2028 (%); 7.5 Online - Market size and forecast 2023-2028; Chart on Online - Market size and forecast 2023-2028 ($ million); Data Table on Online - Market size and forecast 2023-2028 ($ million); Chart on Online - Year-over-year growth 2023-2028 (%); Data Table on Online - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape - 2023-2028 (%); Data Table on Market share By Geographical Landscape - 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 Mexico - Market size and forecast 2023-2028; Chart on Mexico - Market size and forecast 2023-2028 ($ million); Data Table on Mexico - Market size and forecast 2023-2028 ($ million); Chart on Mexico - Year-over-year growth 2023-2028 (%); Data Table on Mexico - Year-over-year growth 2023-2028 (%); 9.4 Brazil - Market size and forecast 2023-2028; Chart on Brazil - Market size and forecast 2023-2028 ($ million); Data Table on Brazil - Market size and forecast 2023-2028 ($ million); Chart on Brazil - Year-over-year growth 2023-2028 (%); Data Table on Brazil - Year-over-year growth 2023-2028 (%); 9.5 Argentina - Market size and forecast 2023-2028; Chart on Argentina - Market size and forecast 2023-2028 ($ million); Data Table on Argentina - Market size and forecast 2023-2028 ($ million); Chart on Argentina - Year-over-year growth 2023-2028 (%); Data Table on Argentina - Year-over-year growth 2023-2028 (%); 9.6 Chile - Market size and forecast 2023-2028; Chart on Chile - Market size and forecast 2023-2028 ($ million); Data Table on Chile - Market size and forecast 2023-2028 ($ million); Chart on Chile - Year-over-year growth 2023-2028 (%); Data Table on Chile - Year-over-year growth 2023-2028 (%); 9.7 Rest of Latin America - Market size and forecast 2023-2028; Chart on Rest of Latin America - Market size and forecast 2023-2028 ($ million); Data Table on Rest of Latin America - Market size and forecast 2023-2028 ($ million); Chart on Rest of Latin America - Year-over-year growth 2023-2028 (%); Data Table on Rest of Latin America - Year-over-year growth 2023-2028 (%); 9.8 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.5 Amneal Pharmaceuticals Inc.; Amneal Pharmaceuticals Inc. - Overview; Amneal Pharmaceuticals Inc. - Business segments; Amneal Pharmaceuticals Inc. - Key news; Amneal Pharmaceuticals Inc. - Key offerings; Amneal Pharmaceuticals Inc. - Segment focus; 12.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.7 Daiichi Sankyo Co. Ltd.; Daiichi Sankyo Co. Ltd. - Overview; Daiichi Sankyo Co. Ltd. - Product / Service; Daiichi Sankyo Co. Ltd. - Key news; Daiichi Sankyo Co. Ltd. - Key offerings; 12.8 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; 12.9 Endo International Plc; Endo International Plc - Overview; Endo International Plc - Business segments; Endo International Plc - Key news; Endo International Plc - Key offerings; Endo International Plc - Segment focus; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 H Lundbeck AS; H Lundbeck AS - Overview; H Lundbeck AS - Product / Service; H Lundbeck AS - Key offerings; 12.12 IntelGenx Technologies Corp.; IntelGenx Technologies Corp. - Overview; IntelGenx Technologies Corp. - Product / Service; IntelGenx Technologies Corp. - Key offerings; 12.13 Klaria Pharma Holding AB; Klaria Pharma Holding AB - Overview; Klaria Pharma Holding AB - Product / Service; Klaria Pharma Holding AB - Key offerings; 12.14 Kowa Co. Ltd.; Kowa Co. Ltd. - Overview; Kowa Co. Ltd. - Product / Service; Kowa Co. Ltd. - Key offerings; 12.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.16 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; 12.17 UCB SA; UCB SA - Overview; UCB SA - Product / Service; UCB SA - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Latin America - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Latin America: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits20: Historic Market Size - Data Table on Migraine Drugs Market in Latin America 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Five forces analysis - Comparison between 2023 and 2028; Exhibits25: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits30: Chart on Market condition - Five forces 2023 and 2028; Exhibits31: Chart on Therapy - Market share 2023-2028 (%); Exhibits32: Data Table on Therapy - Market share 2023-2028 (%); Exhibits33: Chart on Comparison by Therapy; Exhibits34: Data Table on Comparison by Therapy; Exhibits35: Chart on Preventive treatment - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Preventive treatment - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Preventive treatment - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Preventive treatment - Year-over-year growth 2023-2028 (%); Exhibits39: Chart on Abortive treatment - Market size and forecast 2023-2028 ($ million); Exhibits40: Data Table on Abortive treatment - Market size and forecast 2023-2028 ($ million); Exhibits41: Chart on Abortive treatment - Year-over-year growth 2023-2028 (%); Exhibits42: Data Table on Abortive treatment - Year-over-year growth 2023-2028 (%); Exhibits43: Market opportunity by Therapy ($ million); Exhibits44: Data Table on Market opportunity by Therapy ($ million); Exhibits45: Chart on End-user - Market share 2023-2028 (%); Exhibits46: Data Table on End-user - Market share 2023-2028 (%); Exhibits47: Chart on Comparison by End-user; Exhibits48: Data Table on Comparison by End-user; Exhibits49: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Retail - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Retail - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Retail - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Retail - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Online - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Online - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits61: Market opportunity by End-user ($ million); Exhibits62: Data Table on Market opportunity by End-user ($ million); Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits64: Chart on Market share By Geographical Landscape - 2023-2028 (%); Exhibits65: Data Table on Market share By Geographical Landscape - 2023-2028 (%); Exhibits66: Chart on Geographic comparison; Exhibits67: Data Table on Geographic comparison; Exhibits68: Chart on Mexico - Market size and forecast 2023-2028 ($ million); Exhibits69: Data Table on Mexico - Market size and forecast 2023-2028 ($ million); Exhibits70: Chart on Mexico - Year-over-year growth 2023-2028 (%); Exhibits71: Data Table on Mexico - Year-over-year growth 2023-2028 (%); Exhibits72: Chart on Brazil - Market size and forecast 2023-2028 ($ million); Exhibits73: Data Table on Brazil - Market size and forecast 2023-2028 ($ million); Exhibits74: Chart on Brazil - Year-over-year growth 2023-2028 (%); Exhibits75: Data Table on Brazil - Year-over-year growth 2023-2028 (%); Exhibits76: Chart on Argentina - Market size and forecast 2023-2028 ($ million); Exhibits77: Data Table on Argentina - Market size and forecast 2023-2028 ($ million); Exhibits78: Chart on Argentina - Year-over-year growth 2023-2028 (%); Exhibits79: Data Table on Argentina - Year-over-year growth 2023-2028 (%); Exhibits80: Chart on Chile - Market size and forecast 2023-2028 ($ million); Exhibits81: Data Table on Chile - Market size and forecast 2023-2028 ($ million); Exhibits82: Chart on Chile - Year-over-year growth 2023-2028 (%); Exhibits83: Data Table on Chile - Year-over-year growth 2023-2028 (%); Exhibits84: Chart on Rest of Latin America - Market size and forecast 2023-2028 ($ million); Exhibits85: Data Table on Rest of Latin America - Market size and forecast 2023-2028 ($ million); Exhibits86: Chart on Rest of Latin America - Year-over-year growth 2023-2028 (%); Exhibits87: Data Table on Rest of Latin America - Year-over-year growth 2023-2028 (%); Exhibits88: Market opportunity By Geographical Landscape ($ million); Exhibits89: Data Table on Market opportunity By Geographical Landscape ($ million); Exhibits90: Impact of drivers and challenges in 2023 and 2028; Exhibits91: Overview on criticality of inputs and factors of differentiation; Exhibits92: Overview on factors of disruption; Exhibits93: Impact of key risks on business; Exhibits94: Companies covered; Exhibits95: Matrix on companies position and classification; Exhibits96: AbbVie Inc. - Overview; Exhibits97: AbbVie Inc. - Product / Service; Exhibits98: AbbVie Inc. - Key news; Exhibits99: AbbVie Inc. - Key offerings; Exhibits100: Amgen Inc. - Overview; Exhibits101: Amgen Inc. - Product / Service; Exhibits102: Amgen Inc. - Key news; Exhibits103: Amgen Inc. - Key offerings; Exhibits104: Amneal Pharmaceuticals Inc. - Overview; Exhibits105: Amneal Pharmaceuticals Inc. - Business segments; Exhibits106: Amneal Pharmaceuticals Inc. - Key news; Exhibits107: Amneal Pharmaceuticals Inc. - Key offerings; Exhibits108: Amneal Pharmaceuticals Inc. - Segment focus; Exhibits109: Bayer AG - Overview; Exhibits110: Bayer AG - Business segments; Exhibits111: Bayer AG - Key news; Exhibits112: Bayer AG - Key offerings; Exhibits113: Bayer AG - Segment focus; Exhibits114: Daiichi Sankyo Co. Ltd. - Overview; Exhibits115: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits116: Daiichi Sankyo Co. Ltd. - Key news; Exhibits117: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits118: Eli Lilly and Co. - Overview; Exhibits119: Eli Lilly and Co. - Product / Service; Exhibits120: Eli Lilly and Co. - Key offerings; Exhibits121: Endo International Plc - Overview; Exhibits122: Endo International Plc - Business segments; Exhibits123: Endo International Plc - Key news; Exhibits124: Endo International Plc - Key offerings; Exhibits125: Endo International Plc - Segment focus; Exhibits126: GlaxoSmithKline Plc - Overview; Exhibits127: GlaxoSmithKline Plc - Business segments; Exhibits128: GlaxoSmithKline Plc - Key news; Exhibits129: GlaxoSmithKline Plc - Key offerings; Exhibits130: GlaxoSmithKline Plc - Segment focus; Exhibits131: H Lundbeck AS - Overview; Exhibits132: H Lundbeck AS - Product / Service; Exhibits133: H Lundbeck AS - Key offerings; Exhibits134: IntelGenx Technologies Corp. - Overview; Exhibits135: IntelGenx Technologies Corp. - Product / Service; Exhibits136: IntelGenx Technologies Corp. - Key offerings; Exhibits137: Klaria Pharma Holding AB - Overview; Exhibits138: Klaria Pharma Holding AB - Product / Service; Exhibits139: Klaria Pharma Holding AB - Key offerings; Exhibits140: Kowa Co. Ltd. - Overview; Exhibits141: Kowa Co. Ltd. - Product / Service; Exhibits142: Kowa Co. Ltd. - Key offerings; Exhibits143: Pfizer Inc. - Overview; Exhibits144: Pfizer Inc. - Product / Service; Exhibits145: Pfizer Inc. - Key news; Exhibits146: Pfizer Inc. - Key offerings; Exhibits147: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits148: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits149: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits150: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits151: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits152: UCB SA - Overview; Exhibits153: UCB SA - Product / Service; Exhibits154: UCB SA - Key offerings; Exhibits155: Inclusions checklist; Exhibits156: Exclusions checklist; Exhibits157: Currency conversion rates for US$; Exhibits158: Research methodology; Exhibits159: Information sources; Exhibits160: Data validation; Exhibits161: Validation techniques employed for market sizing; Exhibits162: Data synthesis; Exhibits163: 360 degree market analysis; Exhibits164: List of abbreviations